KS 99-407
Alternative Names: KS 99407Latest Information Update: 24 Aug 2006
At a glance
- Originator Kos Pharmaceuticals
- Class Gastrokinetics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastrointestinal disorders
Most Recent Events
- 23 Aug 2006 Discontinued - Phase-I for Gastrointestinal disorders in USA (unspecified route)
- 07 Aug 2003 Preclinical trials in Gastrointestinal disorders in USA (unspecified route)